Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, November 2003, p. 1136-1140, Vol. 10, No. 6
1071-412X/03/$08.00+0 DOI: 10.1128/CDLI.10.6.1136-1140.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Department of Applied Immunology and Microbiology, Wyeth Vaccines Research, Rochester, New York 14623
Received 27 May 2003/ Returned for modification 8 July 2003/ Accepted 21 July 2003
Human sera collected from 28 consenting adult volunteers were used to define assay conditions for meningococcal vaccine clinical trial serology. Immunoassay parameters were optimized with these test sera and the standard reference serum, CDC1992. Coating conditions for serogroup Y and W135 polysaccharide antigens were found to influence the predicted serum immunoglobulin G (IgG) antibody concentrations. Sera that displayed IgG antibody binding profiles most unlike that of CDC1992 were influenced the most by coating conditions. Our results suggest that presentation of specific epitopes is influenced by antigen-coating concentrations for serogroup Y and W135 polysaccharides.
Present address: Ortho-Clinical Diagnostics, Rochester, NY 14626-5101.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»